Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
This substantial decrease shows potential benefits for people with obesity or issues related to their weight
Medicare begins coverage of GLP-1 medications for obesity July 7, 2026 Summary: Starting July 1, 2026, Medicare beneficiaries can access GLP-1 obesity drugs for a flat $50 monthly copay through the CMS Bridge demonstration, an 18-month, taxpayer-funded stopgap created after private insurers balked at the original BALANCE model
Previous research comparing intranasal cyanocobalamin to intramuscular hydroxocobalamin in cobalamin-deficient elderly individuals showed a swift increase in serum cobalamin levels following intranasal administration
At MedStar Health, we focus on caring for the whole person
US$ 20.11
US$ 26.60
US$ 24.14
US$ 20.30
US$ 21.27
US$ 22.20
